Page last updated: 2024-11-08

biguanides and Leukoma

biguanides has been researched along with Leukoma in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guyomarch, J1
van Nuoï, DN1
Beral, L1
Donnio, A1
Desbois, N1
Olive, C1
Theodose, R1
Merle, H1
Wassileva, PI1
Galabov, AS1

Trials

1 trial available for biguanides and Leukoma

ArticleYear
[Treatment of epidemic keratoconjunctivitis with ABOB. Clinical and laboratory investigations (author's transl)].
    Klinische Monatsblatter fur Augenheilkunde, 1975, Volume: 166, Issue:1

    Topics: Adenoviridae Infections; Antiviral Agents; Biguanides; Corneal Opacity; Humans; Keratoconjunctivitis

1975

Other Studies

1 other study available for biguanides and Leukoma

ArticleYear
[Infectious keratitis and cosmetic lenses: a five-case retrospective study].
    Journal francais d'ophtalmologie, 2010, Volume: 33, Issue:4

    Topics: Abscess; Acanthamoeba Keratitis; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; An

2010